In summary, bladder cancer’s alterations in histone modification pathways–whether via mutation (KDM6A, ARID1A, KMT2D) or overexpression (EZH2, HDACs) – are a central component of its biology and interact with aging. The gene discussed is EZH2; the disease is urinary bladder carcinoma.